54 related articles for article (PubMed ID: 8858052)
1. The Key Role of Astrocytes in Amyotrophic Lateral Sclerosis and Their Commitment to Glutamate Excitotoxicity.
Provenzano F; Torazza C; Bonifacino T; Bonanno G; Milanese M
Int J Mol Sci; 2023 Oct; 24(20):. PubMed ID: 37895110
[TBL] [Abstract][Full Text] [Related]
2. Adipose-derived stem cells protect motor neurons and reduce glial activation in both
Ciervo Y; Gatto N; Allen C; Grierson A; Ferraiuolo L; Mead RJ; Shaw PJ
Mol Ther Methods Clin Dev; 2021 Jun; 21():413-433. PubMed ID: 33869658
[TBL] [Abstract][Full Text] [Related]
3. Reprogrammed astrocytes display higher neurogenic competence, migration ability and cell death resistance than reprogrammed fibroblasts.
Xia X; Li C; Wang Y; Deng X; Ma Y; Ding L; Zheng J
Transl Neurodegener; 2020; 9():6. PubMed ID: 32071715
[TBL] [Abstract][Full Text] [Related]
4. Enhanced Function and Overexpression of Metabotropic Glutamate Receptors 1 and 5 in the Spinal Cord of the SOD1
Bonifacino T; Rebosio C; Provenzano F; Torazza C; Balbi M; Milanese M; Raiteri L; Usai C; Fedele E; Bonanno G
Int J Mol Sci; 2019 Sep; 20(18):. PubMed ID: 31540330
[TBL] [Abstract][Full Text] [Related]
5. SOD1-positive aggregate accumulation in the CNS predicts slower disease progression and increased longevity in a mutant SOD1 mouse model of ALS.
Gill C; Phelan JP; Hatzipetros T; Kidd JD; Tassinari VR; Levine B; Wang MZ; Moreno A; Thompson K; Maier M; Grimm J; Gill A; Vieira FG
Sci Rep; 2019 Apr; 9(1):6724. PubMed ID: 31040321
[TBL] [Abstract][Full Text] [Related]
6. Advances, challenges and future directions for stem cell therapy in amyotrophic lateral sclerosis.
Ciervo Y; Ning K; Jun X; Shaw PJ; Mead RJ
Mol Neurodegener; 2017 Nov; 12(1):85. PubMed ID: 29132389
[TBL] [Abstract][Full Text] [Related]
7. What causes amyotrophic lateral sclerosis?
Martin S; Al Khleifat A; Al-Chalabi A
F1000Res; 2017; 6():371. PubMed ID: 28408982
[TBL] [Abstract][Full Text] [Related]
8. Dynein disruption perturbs post-synaptic components and contributes to impaired MuSK clustering at the NMJ: implication in ALS.
Vilmont V; Cadot B; Vezin E; Le Grand F; Gomes ER
Sci Rep; 2016 Jun; 6():27804. PubMed ID: 27283349
[TBL] [Abstract][Full Text] [Related]
9. Neuron-astrocyte interactions in neurodegenerative diseases: Role of neuroinflammation.
Rama Rao KV; Kielian T
Clin Exp Neuroimmunol; 2015 Aug; 6(3):245-263. PubMed ID: 26543505
[TBL] [Abstract][Full Text] [Related]
10. KNS-760704 [(6R)-4,5,6,7-tetrahydro-N6-propyl-2, 6-benzothiazole-diamine dihydrochloride monohydrate] for the treatment of amyotrophic lateral sclerosis.
Gribkoff VK; Bozik ME
CNS Neurosci Ther; 2008; 14(3):215-26. PubMed ID: 18801114
[TBL] [Abstract][Full Text] [Related]
11. Axonal Charcot-Marie-Tooth disease and the neurofilament light gene (NF-L).
Lupski JR
Am J Hum Genet; 2000 Jul; 67(1):8-10. PubMed ID: 10848490
[No Abstract] [Full Text] [Related]
12. A new variant of Charcot-Marie-Tooth disease type 2 is probably the result of a mutation in the neurofilament-light gene.
Mersiyanova IV; Perepelov AV; Polyakov AV; Sitnikov VF; Dadali EL; Oparin RB; Petrin AN; Evgrafov OV
Am J Hum Genet; 2000 Jul; 67(1):37-46. PubMed ID: 10841809
[TBL] [Abstract][Full Text] [Related]
13. Oxidative stress and motor neurone disease.
Cookson MR; Shaw PJ
Brain Pathol; 1999 Jan; 9(1):165-86. PubMed ID: 9989458
[TBL] [Abstract][Full Text] [Related]
14. Protective effect of neurofilament heavy gene overexpression in motor neuron disease induced by mutant superoxide dismutase.
Couillard-Després S; Zhu Q; Wong PC; Price DL; Cleveland DW; Julien JP
Proc Natl Acad Sci U S A; 1998 Aug; 95(16):9626-30. PubMed ID: 9689131
[TBL] [Abstract][Full Text] [Related]
15. Mechanisms of selective motor neuron death in transgenic mouse models of motor neuron disease.
Cleveland DW; Bruijn LI; Wong PC; Marszalek JR; Vechio JD; Lee MK; Xu XS; Borchelt DR; Sisodia SS; Price DL
Neurology; 1996 Oct; 47(4 Suppl 2):S54-61; discussion S61-2. PubMed ID: 8858052
[TBL] [Abstract][Full Text] [Related]
16. Mechanisms of selective motor neuron death in ALS: insights from transgenic mouse models of motor neuron disease.
Bruijn LI; Cleveland DW
Neuropathol Appl Neurobiol; 1996 Oct; 22(5):373-87. PubMed ID: 8930947
[TBL] [Abstract][Full Text] [Related]
17. Absence of neurofilaments reduces the selective vulnerability of motor neurons and slows disease caused by a familial amyotrophic lateral sclerosis-linked superoxide dismutase 1 mutant.
Williamson TL; Bruijn LI; Zhu Q; Anderson KL; Anderson SD; Julien JP; Cleveland DW
Proc Natl Acad Sci U S A; 1998 Aug; 95(16):9631-6. PubMed ID: 9689132
[TBL] [Abstract][Full Text] [Related]
18. Neurofilaments and orthograde transport are reduced in ventral root axons of transgenic mice that express human SOD1 with a G93A mutation.
Zhang B; Tu P; Abtahian F; Trojanowski JQ; Lee VM
J Cell Biol; 1997 Dec; 139(5):1307-15. PubMed ID: 9382875
[TBL] [Abstract][Full Text] [Related]
19. Interleukin-6 Deficiency Does Not Affect Motor Neuron Disease Caused by Superoxide Dismutase 1 Mutation.
Han Y; Ripley B; Serada S; Naka T; Fujimoto M
PLoS One; 2016; 11(4):e0153399. PubMed ID: 27070121
[TBL] [Abstract][Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
